Miguel A. Galan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Miguel A. Galan has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Eva María Martín del Valle
Department of Chemical Engineering , University of Salamanca , Salamanca , Spain
6 shared publications - Antonio Tabernero
Department of Chemical Engineering, University of Salamanca, Plaza de los Caídos s/n, 37001, Salamanca, Spain; Institute of Biomedical Research, Hospital Virgen de la Vega, Paseo San Vicente 58-182, 37007, Salamanca, Spain
3 shared publications - Álvaro González-Garcinuño
Department of Chemical Engineering, University of Salamanca, Salamanca, Spain
2 shared publications - Cristina Rodríguez-Rivero
University of Salamanca
1 shared publication César A Ruiz
Department of Chemical Engineering, University of Salamanca, Plaza de los Caídos 1-5, 37008-Salamanca, Spain
1 shared publicationJ.L. Arranz
Departamento de Ingenierıa Quımica y Textil, Universidad de Salamanca, Salamanca, Spain
1 shared publication
Latest Publications
- Open Access
- 23 May 2017
- Published by Springer Nature in Microbial Cell Factories
- Vol. 16 (1) , 1-11
Effect of bacteria type and sucrose concentration on levan yield and its molecular weight
Levan has been traditionally produced from microorganism. However, there is a continuous effort in looking for new strains that improve levan production yield and uses alternative sugar sources for growth. Despite having a wide range of data about levan yield, there are not papers which allow controlling molecular weight, and that plays an essential role for further applications. The effect of the sucrose concentration on levan yield (and its molecular weight) from Bacillus atrophaeus and Acinetobacter nectaris (Gram positive and Gram negative respectively) was studied in this work. It was found that A. nectaris growth (from 3 to 1.5 g L−1 in 40 h) and its levan production (from 3 to 1.5 g L−1) decreases by increasing sucrose concentration (best results at a concentration of 120 g L−1) whereas B. atrophaeus growth (3.5 g L−1 in 30 h) and its levan production (also 3.5 g L−1) were not affected by modifying that parameter. Levan molecular weight from A. nectaris decreases by increasing sucrose concentration (from 8000 to 2000 kDa) whereas levan molecular weight from B. Atrophaeus remains always around 50 kDa. By performing a kinetic study, it was shown that A. nectaris growth follows a substrate-inhibition model, whereas Monod equation provided a good fit for B. atrophaeus growth. Finally, wastes from orange juice industry were used as a medium culture to cultivate those microorganism, obtaining good results with B. atrophaeus (growth 3 g L−1 in 30 h). Levan production kinetics was determined and compared between different bacteria types.
- 23 May 2017
- Published by Springer Nature in Microbial Cell Factories
- Vol. 16 (1) , 1-11
Open AccessEffect of bacteria type and sucrose concentration on levan yield and its molecular weight
Levan has been traditionally produced from microorganism. However, there is a continuous effort in looking for new strains that improve levan production yield and uses alternative sugar sources for growth. Despite having a wide range of data about levan yield, there are not papers which allow controlling molecular weight, and that plays an essential role for further applications. The effect of the sucrose concentration on levan yield (and its molecular weight) from Bacillus atrophaeus and Acinetobacter nectaris (Gram positive and Gram negative respectively) was studied in this work. It was found that A. nectaris growth (from 3 to 1.5 g L−1 in 40 h) and its levan production (from 3 to 1.5 g L−1) decreases by increasing sucrose concentration (best results at a concentration of 120 g L−1) whereas B. atrophaeus growth (3.5 g L−1 in 30 h) and its levan production (also 3.5 g L−1) were not affected by modifying that parameter. Levan molecular weight from A. nectaris decreases by increasing sucrose concentration (from 8000 to 2000 kDa) whereas levan molecular weight from B. Atrophaeus remains always around 50 kDa. By performing a kinetic study, it was shown that A. nectaris growth follows a substrate-inhibition model, whereas Monod equation provided a good fit for B. atrophaeus growth. Finally, wastes from orange juice industry were used as a medium culture to cultivate those microorganism, obtaining good results with B. atrophaeus (growth 3 g L−1 in 30 h). Levan production kinetics was determined and compared between different bacteria types.
- 23 April 2016
- Published by Walter de Gruyter GmbH in Reviews in Chemical Engineering
- Vol. 32 (5) , 507-532
Survey of supercritical fluid techniques for producing drug delivery systems for a potential use in cancer therapy
Standard drug delivery systems for cancer treatment usually comprise a device with a specific size and shape (depending on the type of cancer that has to be treated), which is composed by a biodegradable compound with a chemotherapeutic entrapped within it. This device should have a molecule (mainly a protein) bound to its surface to target only cancer cells. On the contrary, supercritical fluids (SCF) have been widely used in the pharmaceutical industry for creating drug delivery systems or for extracting drugs from natural sources. This review explains the potential of SCFs for cancer therapies by studying the current uses of the different high-pressure processes that can be useful for this medical treatment, such as the development of new drug delivery systems (with their drug release) or the extraction of chemotherapeutics from a vegetal matrix.
- 23 April 2016
- Published by Walter de Gruyter GmbH in Reviews in Chemical Engineering
- Vol. 32 (5) , 507-532
Survey of supercritical fluid techniques for producing drug delivery systems for a potential use in cancer therapy
Standard drug delivery systems for cancer treatment usually comprise a device with a specific size and shape (depending on the type of cancer that has to be treated), which is composed by a biodegradable compound with a chemotherapeutic entrapped within it. This device should have a molecule (mainly a protein) bound to its surface to target only cancer cells. On the contrary, supercritical fluids (SCF) have been widely used in the pharmaceutical industry for creating drug delivery systems or for extracting drugs from natural sources. This review explains the potential of SCFs for cancer therapies by studying the current uses of the different high-pressure processes that can be useful for this medical treatment, such as the development of new drug delivery systems (with their drug release) or the extraction of chemotherapeutics from a vegetal matrix.
- 12 June 2014
- Published by Springer Nature in Rheologica Acta
- Vol. 53 (7) , 559-570
Rheological characterization of commercial highly viscous alginate solutions in shear and extensional flows
- 12 June 2014
- Published by Springer Nature in Rheologica Acta
- Vol. 53 (7) , 559-570
Rheological characterization of commercial highly viscous alginate solutions in shear and extensional flows
- 21 March 2014
- Published by American Chemical Society (ACS) in Industrial & Engineering Chemistry Research
- Vol. 53 (40) , 15456-15466
Productivity Model for Separation of Proteins Using Ceramic Monoliths As a Stationary Phase
- 21 March 2014
- Published by American Chemical Society (ACS) in Industrial & Engineering Chemistry Research
- Vol. 53 (40) , 15456-15466
Productivity Model for Separation of Proteins Using Ceramic Monoliths As a Stationary Phase
- 20 June 2013
- Published by Walter de Gruyter GmbH in International Journal of Chemical Reactor Engineering
- Vol. 11 (2) , 733-763
Microalgae Technology: A Patent Survey
For a long time now, it is known that an infinite number of compounds can be obtained from microalgae due to their promising composition. This fact is used by several companies to produce at medium-scale different high value products such as carotenoids. Furthermore, this last decade research in this topic has significantly increased given the potential solution these microorganisms present to meet World environmental agreements regarding CO 2 emissions. However, the culture of large-scale microalgae in order to obtain products which are required in huge quantities (e.g., oil for manufacturing biodiesel) and at the same time removing pollutants appeared as a difficult task due to the great number of variables that must be taken into account. The photobioreactor design for cultivating the microalgae is perhaps the most important task, but there are other bottle-necks, such as the harvesting system, cleaning system, control system, the chosen microalgae, and the extraction of products from the microalgae. This review focuses on around 200 patents covering microalgae technology, from different photobioreactors designs to microalgae applications, in order to construct a perfect large-scale facility removing CO 2 in the process.
- 20 June 2013
- Published by Walter de Gruyter GmbH in International Journal of Chemical Reactor Engineering
- Vol. 11 (2) , 733-763
Microalgae Technology: A Patent Survey
For a long time now, it is known that an infinite number of compounds can be obtained from microalgae due to their promising composition. This fact is used by several companies to produce at medium-scale different high value products such as carotenoids. Furthermore, this last decade research in this topic has significantly increased given the potential solution these microorganisms present to meet World environmental agreements regarding CO 2 emissions. However, the culture of large-scale microalgae in order to obtain products which are required in huge quantities (e.g., oil for manufacturing biodiesel) and at the same time removing pollutants appeared as a difficult task due to the great number of variables that must be taken into account. The photobioreactor design for cultivating the microalgae is perhaps the most important task, but there are other bottle-necks, such as the harvesting system, cleaning system, control system, the chosen microalgae, and the extraction of products from the microalgae. This review focuses on around 200 patents covering microalgae technology, from different photobioreactors designs to microalgae applications, in order to construct a perfect large-scale facility removing CO 2 in the process.
- 31 January 2006
- Published by Elsevier in Process Biochemistry
- Vol. 41 (1) , 142-151
Adsorption and mass transfer studies of Catalase in IMAC chromatography by dynamics methods
- 31 January 2006
- Published by Elsevier in Process Biochemistry
- Vol. 41 (1) , 142-151
Adsorption and mass transfer studies of Catalase in IMAC chromatography by dynamics methods
- 17 March 2004
- Published by Wiley in Journal of Chemical Technology & Biotechnology
- Vol. 79 (4) , 321-326
Thermal deactivation and inhibition ofD-Amino acid oxidase in permeabilized cells of the yeastTrigonopsis variabilis
- 17 March 2004
- Published by Wiley in Journal of Chemical Technology & Biotechnology
- Vol. 79 (4) , 321-326
Thermal deactivation and inhibition ofD-Amino acid oxidase in permeabilized cells of the yeastTrigonopsis variabilis
- 8 August 2003
- Published by Elsevier in Applied Catalysis B: Environment and Energy
- Vol. 44 (1) , 41-52
Simulation three-way catalyst ageing Analysis of two conventional catalyst
- 8 August 2003
- Published by Elsevier in Applied Catalysis B: Environment and Energy
- Vol. 44 (1) , 41-52
Simulation three-way catalyst ageing Analysis of two conventional catalyst